| Speaker |
Affiliation |
| Jesse Berlin |
Johnson & Johnson |
| Christy Chuang-Stein |
Pfizer |
| David DeMets, Ph.D. |
Professor of Biostatistics & Medical Informatics, University of Wisconsin-Madison |
| Bill DuMouchel |
Oracle Health Sciences |
| Susan Ellenberg, Ph.D. |
Professor of Biostatistics, Associate Dean for Clinical Research, University of Pennsylvania School of Medicine |
| Thomas Fleming, Ph.D. |
University of Washington and Fred Hutchinson Cancer Research Center |
| Laurence Freedman |
Gertner Institute |
| Robert O’Neill, Ph.D. |
Director, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, US Department of Health & Human Services |
| Margaret Pepe, Ph.D. |
Professor of Biostatistics, University of Washington and Full Member, Biostatistics and Biomathematics Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center |
| Ross Prentice, Ph.D. |
Director, Public Health Sciences Division, Fred Hutchinson Cancer Research Center and Professor of Biostatistics, University of Washington |
| Steve Self, Ph.D. |
Program Head and Full Member, Biostatistics and Biomathematics Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center and Professor of Biostatistics, University of Washington |
| Richard Simon, D.Sc. |
Chief, Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health |
| Robert Temple, M.D. |
Director (Acting), Office of Drug Evaluation I, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, US Department of Health & Human Services |
| Bruce Weir, Ph.D. |
Professor and Chair, Department of Biostatistics, University of Washington |
| John Whittaker |
GlaxoSmithKline |
| Janet Wittes |
Statistics Collaborative, Inc. |
